Ronald Scott

Ronald Scott, Chief Executive Officer (CEO), is a Swiss citizen. He was Basilea's COO from January 2012 through December 2012, and served as Basilea's CFO from the Company's founding in 2000 through January 2012 as well as ad interim CFO from February 7, 2013 until November 4, 2013.

Prior to joining Basilea, he worked for nine years at Roche in management positions in Pharmaceutical Finance, Licensing, and the Roche Corporate Finance Mergers and Acquisitions group.

His assignments included managing Roche's initial call, primary and secondary offerings of Genentech; Roche's biotechnology investment portfolio; acquisitions and divestitures.

Prior to joining Roche, Scott worked for Prudential Investment Corporation in the United States as Director in Prudential's Finance and International Business Development Units, managing divestitures and joint venture transactions.

Ronald Scott is the Chief Executive Officer at Basilea Pharmaceutica. With a background in Biotechnology, Ronald Scott has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.